Abbott has begun the TREAT TR study, to assess the safety and performance of its TriClip TEER system for patients with TR, also referred to as a leaky tricuspid valve.

The post Abbott begins TREAT TR study to assess TriClip for leaky heart valve appeared first on Medical Device Network.